 Hepatitis C
"Hepatitis C" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
INFLAMMATION of the LIVER in humans caused by HEPATITIS C VIRUS, a single-stranded RNA virus. Its incubation period is 30-90 days. Hepatitis C is transmitted primarily by contaminated blood parenterally, and is often associated with transfusion and intravenous drug abuse. However, in a significant number of cases, the source of hepatitis C infection is unknown.
| Descriptor ID |
D006526
|
| MeSH Number(s) |
C02.440.440 C02.782.350.350 C06.552.380.705.440
|
| Concept/Terms |
Hepatitis C- Hepatitis C
- Parenterally-Transmitted Non-A, Non-B Hepatitis
- Parenterally Transmitted Non A, Non B Hepatitis
- PT-NANBH
- Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted
|
Below are MeSH descriptors whose meaning is more general than "Hepatitis C".
Below are MeSH descriptors whose meaning is more specific than "Hepatitis C".
This graph shows the total number of publications written about "Hepatitis C" by people in this website by year, and whether "Hepatitis C" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 3 | 0 | 3 | | 2000 | 2 | 0 | 2 | | 2001 | 1 | 1 | 2 | | 2002 | 2 | 0 | 2 | | 2003 | 4 | 1 | 5 | | 2004 | 6 | 1 | 7 | | 2005 | 5 | 2 | 7 | | 2006 | 7 | 3 | 10 | | 2007 | 4 | 2 | 6 | | 2008 | 4 | 1 | 5 | | 2009 | 5 | 1 | 6 | | 2010 | 8 | 2 | 10 | | 2011 | 9 | 1 | 10 | | 2012 | 3 | 0 | 3 | | 2013 | 5 | 0 | 5 | | 2014 | 4 | 3 | 7 | | 2015 | 14 | 1 | 15 | | 2016 | 7 | 1 | 8 | | 2017 | 9 | 2 | 11 | | 2018 | 7 | 2 | 9 | | 2019 | 8 | 1 | 9 | | 2020 | 7 | 2 | 9 | | 2021 | 5 | 1 | 6 | | 2022 | 12 | 0 | 12 | | 2023 | 6 | 0 | 6 | | 2024 | 2 | 3 | 5 | | 2025 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Hepatitis C" by people in Profiles.
-
Torres TS, Saha PT, Smeaton L, Wimbish C, Kliemann DA, Avihingsanon A, Kityo C, Bennet JA, Van Schalkwyk M, Linas B, Nunes EP, Robbins GK, Wyles D, Naggie S, Sulkowski M, Cardoso SW, Solomon S. Impact of a minimal monitoring HCV treatment approach on Health-Related Quality of Life. Qual Life Res. 2025 Jun; 34(6):1683-1694.
-
Toerper MF, Haukoos J, Hopkins E, Rowan SE, Lyons MS, Galbraith JW, Hsieh YH, White DA, Levin S, Hinson J, Rothman RE. Use of Epic? to facilitate high-quality randomization of emergency department-based pragmatic clinical trials. Clin Trials. 2025 Apr; 22(2):142-151.
-
Bredenberg E, Callister C, Dafoe A, Holliman BD, Rowan SE, Calcaterra SL. Subspecialty physicians' perspectives on barriers and facilitators of hepatitis C treatment: a qualitative study. Harm Reduct J. 2024 07 25; 21(1):140.
-
McGaffey A, Castelli G, Friedlander MP, Proddutur S, Simpkins C, Middleton DB, Spencer KO, Taormina JM, Gerlach A, Nowalk MP. Going (Anti)Viral: Improving HIV and HCV Screening and HPV Vaccination in Primary Care. Jt Comm J Qual Patient Saf. 2024 09; 50(9):645-654.
-
Work HM, Hackett JC, Lampe JN. HCV Antiviral Drugs Have the Potential to Adversely Perturb the Fetal-Maternal Communication Axis through Inhibition of CYP3A7 DHEA-S Oxidation. Drug Metab Dispos. 2024 May 16; 52(6):516-525.
-
Rowan SE, Wyles DL. Don't Put Off Until Tomorrow What You Can Do Today: Hospital Admissions as an Opportunity to Treat Hepatitis C. Clin Infect Dis. 2024 03 20; 78(3):591-593.
-
Grasch JL, de Voest JA, Saade GR, Hughes BL, Reddy UM, Costantine MM, Chien EK, Tita ATN, Thorp JM, Metz TD, Wapner RJ, Sabharwal V, Simhan HN, Swamy GK, Heyborne KD, Sibai BM, Grobman WA, El-Sayed YY, Casey BM, Parry S. Breastfeeding Initiation, Duration, and Associated Factors Among People With Hepatitis C Virus Infection. Obstet Gynecol. 2024 Mar 01; 143(3):449-455.
-
Amancherla K, Feurer ID, Rega SA, Cluckey A, Salih M, Davis J, Pedrotty D, Ooi H, Rali AS, Siddiqi HK, Menachem J, Brinkley DM, Punnoose L, Sacks SB, Zalawadiya SK, Wigger M, Balsara K, Trahanas J, McMaster WG, Hoffman J, Pasrija C, Lindenfeld J, Shah AS, Schlendorf KH. Early Assessment of Cardiac Allograft Vasculopathy Risk Among Recipients of Hepatitis C Virus-infected Donors in the Current Era. J Card Fail. 2024 May; 30(5):694-700.
-
Prasad M, Saade GR, Clifton RG, Sandoval GJ, Hughes BL, Reddy UM, Bartholomew A, Salazar A, Chien EK, Tita ATN, Thorp JM, Metz TD, Wapner RJ, Sabharwal V, Simhan HN, Swamy GK, Heyborne KD, Sibai BM, Grobman WA, El-Sayed YY, Casey BM, Parry S, Rathore M, Diaz-Velasco R, Puga AM, Wiznia A, Kovacs A, Garry DJ, Macones GA. Risk Factors for Perinatal Transmission of Hepatitis C Virus. Obstet Gynecol. 2023 09 01; 142(3):449-456.
-
Garimella PS, Scherzer R, Kestenbaum BR, Hoofnagle AN, Jotwani V, Gustafson D, Karim R, Sharma A, Cohen M, Dumond J, Abraham A, Estrella M, Shlipak MG, Ix JH. Tubular Secretory Solute Clearance and HIV Infection. J Acquir Immune Defic Syndr. 2023 08 01; 93(4):319-326.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|